机译:尽管甲氨蝶呤治疗,但在输卵管异位妊娠破裂患者中危险因素和人绒毛膜促性腺激素趋势
Department of Obstetrics and Gynecology Weill Cornell Medical College;
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Weill Cornell Medical;
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Weill Cornell Medical;
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Weill Cornell Medical;
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Weill Cornell Medical;
The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Weill Cornell Medical;
机译:尽管甲氨蝶呤治疗,但在输卵管异位妊娠破裂患者中危险因素和人绒毛膜促性腺激素趋势
机译:尽管甲氨蝶呤治疗,但在输卵管异位妊娠破裂患者中危险因素和人绒毛膜促性腺激素趋势
机译:尽管甲氨蝶呤治疗,但在输卵管异位妊娠破裂患者中危险因素和人绒毛膜促性腺激素趋势
机译:一种独特的疫苗,用于控制生育率和治疗晚期终端癌症的癌症,异常表达人绒毛膜促性腺激素
机译:人类早期妊娠的绒毛膜促性腺激素模式和妊娠结局的早期标志物。
机译:人绒毛膜促性腺激素值及其在甲氨蝶呤治疗之前的变化可预测异位输卵管妊娠的预后
机译:尽管甲氨蝶呤治疗,输卵管异位妊娠破裂患者的危险因素和HCG趋势